• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同类型糖尿病对血管并发症的影响。

The Influence of Different Types of Diabetes on Vascular Complications.

机构信息

Changchun University of Chinese Medicine, Changchun 130117, China.

Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

出版信息

J Diabetes Res. 2022 Feb 22;2022:3448618. doi: 10.1155/2022/3448618. eCollection 2022.

DOI:10.1155/2022/3448618
PMID:35242879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8888068/
Abstract

The final outcome of diabetes is chronic complications, of which vascular complications are the most serious, which is the main cause of death for diabetic patients and the direct cause of the increase in the cost of diabetes. Type 1 and type 2 diabetes are the main types of diabetes, and their pathogenesis is completely different. Type 1 diabetes is caused by genetics and immunity to destroy a large number of cells, and insulin secretion is absolutely insufficient, which is more prone to microvascular complications. Type 2 diabetes is dominated by insulin resistance, leading to atherosclerosis, which is more likely to progress to macrovascular complications. This article explores the pathogenesis of two types of diabetes, analyzes the pathogenesis of different vascular complications, and tries to explain the different trends in the progression of different types of diabetes to vascular complications, in order to better prevent diabetes and its vascular complications.

摘要

糖尿病的最终结果是慢性并发症,其中血管并发症最为严重,这是糖尿病患者死亡的主要原因,也是糖尿病费用增加的直接原因。1 型和 2 型糖尿病是糖尿病的主要类型,其发病机制完全不同。1 型糖尿病是由遗传和免疫引起的,会大量破坏细胞,胰岛素分泌绝对不足,更容易发生微血管并发症。2 型糖尿病以胰岛素抵抗为主,导致动脉粥样硬化,更容易发展为大血管并发症。本文探讨了两种类型糖尿病的发病机制,分析了不同血管并发症的发病机制,并试图解释不同类型糖尿病向血管并发症进展的不同趋势,以期更好地预防糖尿病及其血管并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0496/8888068/036b48de5738/JDR2022-3448618.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0496/8888068/d26ec121f296/JDR2022-3448618.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0496/8888068/036b48de5738/JDR2022-3448618.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0496/8888068/d26ec121f296/JDR2022-3448618.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0496/8888068/036b48de5738/JDR2022-3448618.002.jpg

相似文献

1
The Influence of Different Types of Diabetes on Vascular Complications.不同类型糖尿病对血管并发症的影响。
J Diabetes Res. 2022 Feb 22;2022:3448618. doi: 10.1155/2022/3448618. eCollection 2022.
2
Symptoms and complications of adult diabetic patients in a family practice.家庭医疗中成年糖尿病患者的症状与并发症
Arch Fam Med. 1996 Mar;5(3):135-45. doi: 10.1001/archfami.5.3.135.
3
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.非酒精性脂肪性肝病与糖尿病的慢性血管并发症。
Nat Rev Endocrinol. 2018 Feb;14(2):99-114. doi: 10.1038/nrendo.2017.173. Epub 2017 Dec 29.
4
Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: their role in the prediction of vascular complications.可溶性血管内皮蛋白 C 受体和高敏 C 反应蛋白水平作为 1 型和 2 型糖尿病患者血管内皮功能障碍的标志物:它们在预测血管并发症中的作用。
Diabetes Res Clin Pract. 2014 Dec;106(3):597-604. doi: 10.1016/j.diabres.2014.09.007. Epub 2014 Sep 30.
5
Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.糖尿病大血管并发症与糖尿病微血管并发症风险增加相关:英国生物库中 1518 例 1 型糖尿病患者和 20802 例 2 型糖尿病患者的前瞻性研究。
J Am Heart Assoc. 2024 Jun 4;13(11):e032626. doi: 10.1161/JAHA.123.032626. Epub 2024 May 31.
6
Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics.糖尿病大血管疾病的危险因素:世界卫生组织糖尿病患者血管疾病多国研究的伦敦随访研究
Diabetologia. 1991 Aug;34(8):590-4. doi: 10.1007/BF00400279.
7
Vascular dysfunction in diabetes mellitus.糖尿病中的血管功能障碍。
Lancet. 1997 Jul;350 Suppl 1:SI9-13. doi: 10.1016/s0140-6736(97)90022-2.
8
Animal models of diabetes mellitus: relevance to vascular complications.糖尿病动物模型:与血管并发症的相关性
Curr Pharm Des. 2008;14(4):309-24. doi: 10.2174/138161208783497679.
9
Diabetes microvascular complications-A clinical update.糖尿病微血管并发症——临床最新进展
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S133-S139. doi: 10.1016/j.dsx.2016.12.022. Epub 2016 Dec 13.
10
Cross-sectional pilot study about the health status of diabetic patients in city of Misurata, Libya.关于利比亚米苏拉塔市糖尿病患者健康状况的横断面试点研究。
Afr Health Sci. 2012 Mar;12(1):81-6.

引用本文的文献

1
Oxidative-Inflammatory Crosstalk and Multi-Target Natural Agents: Decoding Diabetic Vascular Complications.氧化-炎症相互作用与多靶点天然药物:解读糖尿病血管并发症
Curr Issues Mol Biol. 2025 Aug 4;47(8):614. doi: 10.3390/cimb47080614.
2
Hesperetin and Isoliquiritigenin Attenuate the Progression of Diabetic Nephropathy via Inhibition of NF-κB/NLRP3 Pathways in Type 2 Diabetic Rats.橙皮素和异甘草素通过抑制2型糖尿病大鼠的NF-κB/NLRP3信号通路减轻糖尿病肾病进展
ACS Omega. 2025 Jul 30;10(31):34342-34351. doi: 10.1021/acsomega.5c02026. eCollection 2025 Aug 12.
3
Global, Regional, and National Epidemiology of Vision Impairment due to Diabetic Retinopathy Among Working-Age Population, 1990-2021.

本文引用的文献

1
The Role of NADPH Oxidase in Neuronal Death and Neurogenesis after Acute Neurological Disorders.NADPH氧化酶在急性神经系统疾病后神经元死亡和神经发生中的作用。
Antioxidants (Basel). 2021 May 7;10(5):739. doi: 10.3390/antiox10050739.
2
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
3
Tumor necrosis factor-α blockade ameliorates diabetic nephropathy in rats.肿瘤坏死因子-α阻断可改善大鼠糖尿病肾病。
1990 - 2021年工作年龄人群中糖尿病性视网膜病变所致视力损害的全球、区域和国家流行病学情况
J Diabetes. 2025 Jul;17(7):e70121. doi: 10.1111/1753-0407.70121.
4
The Potential Effect of Dapagliflozin and Liraglutide in Attenuating Cardio-Renal Injuries in Diabetic Rats.达格列净和利拉鲁肽对减轻糖尿病大鼠心肾损伤的潜在作用。
J Exp Pharmacol. 2025 Jul 7;17:467-484. doi: 10.2147/JEP.S522053. eCollection 2025.
5
Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments.糖尿病及相关血管疾病:发病机制、并发症与不断发展的治疗方法
Adv Ther. 2025 Jun;42(6):2659-2678. doi: 10.1007/s12325-025-03185-9. Epub 2025 Apr 19.
6
[Research progress on automated insulin delivery system in the field of diabetes management].[糖尿病管理领域自动胰岛素输送系统的研究进展]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024 Dec 25;41(6):1279-1285. doi: 10.7507/1001-5515.202406060.
7
The efficacy and safety of qiwei baizhu san in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis.七味白术散治疗2型糖尿病的疗效与安全性:一项系统评价与Meta分析
Front Pharmacol. 2025 Jan 7;15:1501990. doi: 10.3389/fphar.2024.1501990. eCollection 2024.
8
Assessing intention to use mobile phone-based self-management support among adults with type 2 diabetes in Saudi Arabia: A cross-sectional study.评估沙特阿拉伯2型糖尿病成年人使用基于手机的自我管理支持的意愿:一项横断面研究。
Digit Health. 2025 Jan 10;11:20552076241308993. doi: 10.1177/20552076241308993. eCollection 2025 Jan-Dec.
9
Effect of Barley on Postprandial Blood Glucose Response and Appetite in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial.大麦对健康个体餐后血糖反应和食欲的影响:一项随机、双盲、安慰剂对照试验。
Nutrients. 2024 Nov 15;16(22):3899. doi: 10.3390/nu16223899.
10
Assessment of neutrophil/lymphocyte ratio and mean platelet volume values in patients with diabetes mellitus diagnosis: A case-control study.评估诊断为糖尿病的患者中性粒细胞/淋巴细胞比值和平均血小板体积值:一项病例对照研究。
Medicine (Baltimore). 2024 Sep 13;103(37):e39661. doi: 10.1097/MD.0000000000039661.
Clin Kidney J. 2019 Nov 7;14(1):301-308. doi: 10.1093/ckj/sfz137. eCollection 2021 Jan.
4
Tissue Acidosis Associated with Ischemic Stroke to Guide Neuroprotective Drug Delivery.与缺血性中风相关的组织酸中毒以指导神经保护药物递送。
Biology (Basel). 2020 Dec 11;9(12):460. doi: 10.3390/biology9120460.
5
Diabetes and stroke: An important complication.糖尿病与中风:一种重要的并发症。
J Diabetes. 2021 Mar;13(3):184-190. doi: 10.1111/1753-0407.13142. Epub 2020 Dec 27.
6
Deletion of NoxO1 limits atherosclerosis development in female mice.NoxO1 的缺失限制了雌性小鼠动脉粥样硬化的发展。
Redox Biol. 2020 Oct;37:101713. doi: 10.1016/j.redox.2020.101713. Epub 2020 Sep 4.
7
Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing.由FOXM1精心编排的免疫细胞募集失调会损害人类糖尿病伤口愈合。
Nat Commun. 2020 Sep 16;11(1):4678. doi: 10.1038/s41467-020-18276-0.
8
Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017.2017 年全球疾病负担研究:1990 年至 2017 年 2 型糖尿病导致的慢性肾脏病流行趋势变化。
J Diabetes Investig. 2021 Mar;12(3):346-356. doi: 10.1111/jdi.13355. Epub 2020 Aug 17.
9
Endothelial Dysfunction in Diabetes.糖尿病中的内皮功能障碍
Biomedicines. 2020 Jun 29;8(7):182. doi: 10.3390/biomedicines8070182.
10
Genome-wide analysis of DNA methylation identifies S100A13 as an epigenetic biomarker in individuals with chronic (≥ 30 years) type 2 diabetes without diabetic retinopathy.全基因组 DNA 甲基化分析鉴定出 S100A13 是慢性(≥30 年)2 型糖尿病而无糖尿病视网膜病变个体的表观遗传生物标志物。
Clin Epigenetics. 2020 Jun 3;12(1):77. doi: 10.1186/s13148-020-00871-z.